IDEAYA Biosciences, Inc. - Common Stock (IDYA)

CUSIP: 45166A102

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock
Shares outstanding
87,836,000
Total 13F shares
5,572,657
Share change
-81,068
Total reported value
$49,467,000
Price per share
$9.00
Number of holders
24
Value change
-$827,584
Number of buys
9
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BVF INC/IL
13F
Company
1.7%
1,505,429
$14,994,000 30 Jun 2019
13F
PERCEPTIVE ADVISORS LLC
13F
Company
1.3%
1,141,484
$11,369,000 30 Jun 2019
13F
Boxer Capital, LLC
13F
Company
0.87%
764,252
$7,612,000 30 Jun 2019
13F
Alphabet Inc.
13F
Company
0.86%
753,187
$7,502,000 30 Jun 2019
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.48%
425,000
$4,233,000 30 Jun 2019
13F
BAKER BROS. ADVISORS LP
13F
Company
0.23%
200,000
$1,992,000 30 Jun 2019
13F
Point72 Asset Management, L.P.
13F
Company
0.22%
195,567
$1,948,000 30 Jun 2019
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.2%
174,083
$1,734,000 30 Jun 2019
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.17%
145,880
$1,453,000 30 Jun 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.13%
118,407
$1,179,000 30 Jun 2019
13F
DC Investments Management, LLC
13F
Company
0.06%
53,620
$534,000 30 Jun 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.05%
43,433
$433,000 30 Jun 2019
13F
Monashee Investment Management LLC
13F
Company
0.04%
35,546
$354,000 30 Jun 2019
13F
VANGUARD GROUP INC
13F
Company
0.04%
35,000
$349,000 30 Jun 2019
13F
Laurion Capital Management LP
13F
Company
0.02%
20,000
$199,000 30 Jun 2019
13F
BlueCrest Capital Management Ltd
13F
Company
0.02%
15,000
$149,000 30 Jun 2019
13F
NORGES BANK
13F
Company
0.01%
10,000
$100,000 30 Jun 2019
13F
BlackRock Finance, Inc.
13F
Company
0.01%
8,263
$82,000 30 Jun 2019
13F
Cubist Systematic Strategies, LLC
13F
Company
0.01%
4,969
$49,000 30 Jun 2019
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
1,986
$20,000 30 Jun 2019
13F
Point72 Hong Kong Ltd
13F
Company
0%
1,243
$12,000 30 Jun 2019
13F
Winslow, Evans & Crocker, Inc.
13F
Company
0%
440
$6,000 30 Jun 2019
13F
US BANCORP \DE\
13F
Company
0%
500
$5,000 30 Jun 2019
13F
Catalyst Capital Advisors LLC
13F
Company
0%
436
$4,000 30 Jun 2019
13F

Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q3 2019

As of 30 Sep 2019, IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,572,657 shares. The largest 10 holders included BVF INC/IL, PERCEPTIVE ADVISORS LLC, BOXER CAPITAL, LLC, Alphabet Inc., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., DRIEHAUS CAPITAL MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, and VANGUARD GROUP INC. This page lists 24 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
24
Q3 2019 holders
24
Holder diff
0
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 Value $ Q3 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.